Therapeutic compositions to enhance the effect of Antibody Therapy against the epidermal growth factor receptor

摘要

1. - a Therapeutic composition useful in the treatment of cancer which comprises the simultaneous or Sequential Administration of an Antibody against the EGF receptor and one or more types of interferons 1.2.The therapeutic Composition of claim 1, characterized in that it comprises an Antibody against the EGF receptor, interferon and an appropriate carrier for Administration via intravenosa.3. - Therapeutic Composition of claims 1 and 2, wherein the Monoclonal antibody against the EGF receptor is a Chimeric Antibody.The therapeutic Composition of claim 3 wherein the monoclonal antibody against the EGF receptor is an Antibody humanizado.5. - Therapeutic Composition of claim 4 wherein the monoclonal antibody against the EGF receptor is the ancient RPO Humanized HR3 produced by the cell line with the number of 951110101.6 deposit.The therapeutic Composition of claim 1 and 2, wherein the Interferon Type is 1.7 Therapeutic Composition of claim 6 wherein the interferon is INF - - humano.8. Therapeutic Composition of claim 7 wherein the R Recombinant human interferon is INF -. 9.A Therapeutic composition characterized in that it comprises the HR3 monoclonal antibody against the EGF receptor produced by the cell line with no deposit. 951110101 and recombinant human interferon INF -.